BLCM — Bellicum Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.95m
- -$4.96m
- $1.50m
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview
Bellicum Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Bellicum Pharmaceuticals Inc - QTRLY Loss Per Share $0.13
Bellicum Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview
Bellicum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Bellicum Files For Mixed Shelf Of Up To $200 Million
Bellicum Pharmaceuticals Inc expected to post a loss of 70 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-BioLine RX, Pitney Bowes, Atea Pharma
U.S. STOCKS ON THE MOVE-BioLine RX Ltd, Bellicum Pharma, MoneyGram
U.S. STOCKS ON THE MOVE-BioLine RX, Bellicum Pharma, Mohawk Industries
U.S. STOCKS ON THE MOVE-BioLine RX, Axovant, Bellicum Pharma
Brief: Bellicum Pharmaceuticals Got Approval From Nasdaq to Transfer Listing Of Common Stock
Brief: Bellicum Receives FDA IND Clearance To Initiate Phase 1/2 Clinical Trial For BPX-603
Brief: Bellicum Pharma - M.D. Anderson To Resume Selected Research, Manufacturing Activities
Brief: Bellicum Pharmaceuticals Says M.D. Anderson To Temporarily Halt Research Activity
Brief: Bellicum Completes Sale Of Houston Facility